Skip to content
Descubridor Institucional UMAR
Inicio
Búsqueda avanzada
Explorar
Inicio
Búsqueda avanzada
Explorar
Login
Language
English
Deutsch
Español
Français
Italiano
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
The impact of emicizumab on the clinical validation of new therapies for haemophilia A
The impact of emicizumab on the clinical validation of new therapies for haemophilia A
Fuente:
Wiley Open Access
Saved in:
Bibliographic Details
Main Authors:
Cedric Hermans
,
Catherine Lambert
,
Sébastien Lobet
,
Evelien Krumb
,
An Van Damme
Format:
Artículo Open Access
Published:
Wiley
2024
Subjects:
Haemophilia
Online Access:
Acceder al recurso
Tags:
Add Tag
No Tags, Be the first to tag this record!
Cite this
Text this
Email this
Print
Export Record
Export to RefWorks
Export to EndNoteWeb
Export to EndNote
Save to List
Permanent link
Holdings
Description
Comments
Similar Items
Staff View
Be the first to leave a comment!
Your Comment
You must be logged in first
Similar Items
Haemophilic Elbow Arthropathy: Mechanisms, Management and Future Perspectives
by: Sébastien Lobet, et al.
Published: (2025)
Low‐dose emicizumab for more equitable access to prophylaxis in resource limited countries
by: Pier Mannuccio Mannucci, et al.
Published: (2024)
Transitioning patients with severe haemophilia A from emicizumab prophylaxis to valoctocogene roxaparvovec gene therapy: Real‐world clinical experience
by: Robert Klamroth, et al.
Published: (2024)
Women and girls with inherited bleeding disorders: Focus on haemophilia carriers and heavy menstrual bleeding
by: Cedric Hermans, et al.
Published: (2024)
Measurement of recombinant porcine factor VIII in patients with congenital haemophilia A and inhibitors in the presence of emicizumab
by: Christian Pfrepper, et al.
Published: (2024)